Biopolymers have become very attractive as they are degradable, biocompatible, non-toxic
and renewable. Due to the intrinsic reactive amino groups, chitosan is vibrant in the midst of …

Type 1 and advanced type 2 diabetes treatment involves daily injections or continuous
infusion of exogenous insulin aimed at regulating blood glucose levels in the …

Type 1 diabetes therapies that afford tighter glycemic control in a more manageable and
painless manner for patients has remained a central focus of next-generation diabetes …

Diabetes mellitus (DM) refers to a group of metabolic disorders that are characterized by
hyperglycemia. Oral subcutaneously administered antidiabetic drugs such as insulin …

Diabetes is a disorder of glucose regulation, which is performed by an accumulating of
glucose concentration in the blood. Although it is a chronic disease, it threatens human …

Glucose‐responsive insulin‐delivery platforms that are sensitive to dynamic glucose
concentration fluctuations and provide both rapid and prolonged insulin release have great …

Recent advances and applications of biomolecule‐responsive hydrogels, namely, glucose‐
responsive hydrogels, protein‐responsive hydrogels, and nucleic‐acid‐responsive …

Designing strategies for the use of biopolymer-based nanoparticles as drug delivery carriers
is a considerable challenge in pharmaceutical science. Present study reports synthesis of a …

This review is focused on the materials and methods used to fabricate closed‐loop systems
for type 1 diabetes therapy. Herein, we give a brief overview of current methods used for …

A “closed-loop” insulin delivery system that can mimic the dynamic and glucose-responsive
insulin secretion as islet β-cells is desirable for the therapy of type 1 and advanced type 2 …